Skip to main content

Market Overview

29 Healthcare Stocks Moving In Friday's After-Market Session

Share:

Gainers

  • ADMA Biologics, Inc. (NASDAQ: ADMA) shares surged 13.2% to $3.94 during Friday's after-market session. The market value of their outstanding shares is at $210.5 million. The most recent rating by Jefferies, on June 04, is at Buy, with a price target of $8.00.
  • Gemphire Therapeutics, Inc. (NASDAQ: GEMP) shares moved upwards by 8.6% to $0.67. The market value of their outstanding shares is at $9.6 million.
  • Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) stock surged 6.8% to $10.85. The market cap seems to be at $215.8 million.
  • Obalon Therapeutics, Inc. (NASDAQ: OBLN) shares rose 5.5% to $3.42. The market value of their outstanding shares is at $17.2 million.
  • Acorda Therapeutics, Inc. (NASDAQ: ACOR) stock increased by 5.2% to $3.25. The market cap stands at $292.1 million. The most recent rating by Wedbush, on August 02, is at Neutral, with a price target of $7.00.
  • Proteostasis Therapeutics, Inc. (NASDAQ: PTI) shares rose 5.0% to $0.85. The market cap stands at $42.7 million.
  • TG Therapeutics, Inc. (NASDAQ: TGTX) stock moved upwards by 4.9% to $7.43. The market cap stands at $665.8 million.
  • Leap Therapeutics, Inc. (NASDAQ: LPTX) shares rose 4.4% to $2.39. The market cap stands at $51.6 million.
  • Precipio, Inc. (NASDAQ: PRPO) shares rose 4.2% to $2.98. The market cap stands at $17.2 million.
  • Global Blood Therapeutics, Inc. (NASDAQ: GBT) shares surged 4.0% to $54.45. The market value of their outstanding shares is at $3.2 billion. The most recent rating by Goldman Sachs, on May 29, is at Neutral, with a price target of $75.00.
  • TherapeuticsMD, Inc. (NASDAQ: TXMD) shares increased by 4.0% to $2.10. The market cap stands at $511.3 million.
  • Abiomed, Inc. (NASDAQ: ABMD) stock increased by 3.9% to $208.50. The market cap stands at $9.2 billion. The most recent rating by Morgan Stanley, on August 02, is at Equal-Weight, with a price target of $215.00.
  • Provention Bio, Inc. (NASDAQ: PRVB) stock increased by 3.3% to $11.00. The market cap stands at $375.4 million. The most recent rating by Chardan Capital, on June 10, is at Buy, with a price target of $20.00.
  • Sundial Growers, Inc. (NASDAQ: SNDL) shares rose 2.9% to $10.75. The market cap stands at $702.2 million.
  • Kala Pharmaceuticals, Inc. (NASDAQ: KALA) stock rose 2.8% to $5.96. The market cap stands at $201.6 million.
  • Aclaris Therapeutics, Inc. (NASDAQ: ACRS) stock increased by 2.7% to $1.14. The market cap seems to be at $49.9 million. According to the most recent rating by SVB Leerink, on June 27, the current rating is at Market Perform.
  • Corbus Pharmaceuticals, Inc. (NASDAQ: CRBP) stock increased by 2.6% to $5.80. The market value of their outstanding shares is at $385.4 million.
  • Histogenics, Inc. (NASDAQ: HSGX) stock moved upwards by 2.6% to $0.20. The market value of their outstanding shares is at $17.3 million.
  • Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) shares moved upwards by 2.5% to $1.23. The market value of their outstanding shares is at $139.2 million. The most recent rating by Citigroup, on July 30, is at Buy, with a price target of $3.00.
  • Intec Pharma, Inc. (NASDAQ: NTEC) shares increased by 2.1% to $0.52. The market cap stands at $15.5 million.
  • Neurocrine Biosciences, Inc. (NASDAQ: NBIX) shares increased by 2.1% to $96.00. The market cap seems to be at $8.7 billion. The most recent rating by Piper Jaffray, on July 30, is at Overweight, with a price target of $111.00.
  • Moderna, Inc. (NASDAQ: MRNA) shares surged 2.0% to $12.99. The market cap seems to be at $4.2 billion.

 

Losers

  • GlycoMimetics, Inc. (NASDAQ: GLYC) shares plummeted 39.8% to $5.50 during Friday's after-market session. The market cap stands at $399.4 million.
  • Plus Therapeutics, Inc. (NASDAQ: PSTV) shares declined 12.9% to $0.17. The market value of their outstanding shares is at $4.4 million.
  • Conatus Pharmaceuticals, Inc. (NASDAQ: CNAT) shares fell 6.0% to $0.31. The market value of their outstanding shares is at $10.2 million.
  • Viveve Medical, Inc. (NASDAQ: VIVE) shares plummeted 4.9% to $0.15. The market cap seems to be at $7.3 million. According to the most recent rating by Ladenburg Thalmann, on July 24, the current rating is at Neutral.
  • Novavax, Inc. (NASDAQ: NVAX) shares declined 2.5% to $4.23. The market value of their outstanding shares is at $106.5 million.
  • CannTrust Holdings, Inc. (NYSE: CTST) stock plummeted 2.2% to $2.22. The market value of their outstanding shares is at $307.0 million. According to the most recent rating by Roth Capital, on July 09, the current rating is at Neutral.
  • Innovate, Inc. (NASDAQ: INNT) shares decreased by 2.0% to $0.92. The market cap seems to be at $35.7 million.
 

Related Articles (ABMD + ACOR)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks After-Market MoversNews Movers & Shakers After-Hours Center Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com